Join Hubwonk host Joe Selvaggi as he talks with Hannah Mamuszka, expert in diagnostic science, about the state of COVID-19 testing technology and its implications for a safer return to school and work in the fall.
Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.
Oops! We could not locate your form.
Related Content:
Learning From California: Policy Lessons From Golden State Exodus
New England Short Circuit: Distorted Incentives Drive Energy Prices Up and Reliability Down
Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma
Harris’ Tax Vision: Policy & Politics
Digital Privacy Divide: Can Law Enforcement Google Where You’ve Been?
Housing Bond Bill: Could Billions Better Bay State Cost of Living
Ruinous Red Tape: Epic Cost of Unchecked Federal Rule Making
Property Tax Reassessment: Beleaguered Buildings Bear Burden of Boston’s Burgeoning Budget
Registering Republican Realignment: GOP Convention Showcases Conservatism’s New Direction
Candidate Selection Breakdown: Presidential Primary Primacy or Determined Delegate Detour
Breaking Down Encampments: Court Finds no Right to Sleep Outdoors
